No evidence for relevant QT interval prolongation in mitotane-treated patients with adrenocortical carcinoma. [electronic resource]
Producer: 20130528Description: 911-4 p. digitalISSN:- 1720-8386
- Adrenal Cortex Neoplasms -- complications
- Adrenocortical Carcinoma -- complications
- Adult
- Aged
- Antineoplastic Agents, Hormonal -- therapeutic use
- Electrocardiography
- Female
- Follow-Up Studies
- Hospitalization
- Humans
- Long QT Syndrome -- etiology
- Male
- Middle Aged
- Mitotane -- therapeutic use
- Prognosis
- Retrospective Studies
- Risk Factors
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.